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Conclusion: This study shows an high consistency of small 
field dosimetry in the involved radiotherapy departments 
using this new generation silicon diode; consequently, the 
values reported may actually be used by other centers as 
indicative values, especially in the case of small fields when 
suitable detector are not commonly available. Moreover, 
these results confirm that the new RAZOR silicon diode can 
be used to assess dosimetric accuracy in small-field delivery. 
In general, the adopted methodology removes much of the 
ambiguity in reporting and interpreting small field dosimetric 
quantities and facilitates a clear dosimetric comparison 
across a population of linacs. 
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Purpose or Objective: Outlining of target and OAR volumes 
is integral to the radiotherapy process but inherently subject 
to variability. The hippocampus is a small structure not 
commonly contoured by clinicians requiring considered 
anatomical interpretation in its delineation. HIPPO is a 
randomised phase II trial of Hippocampal Sparing (HS) versus 
Conventional Whole Brain Radiotherapy after surgical 
resection or radiosurgery in favourable prognosis patients 
with 1-4 brain metastases. We set out to inform the 
development of a dedicated HIPPO RTQA programme through 
evaluation of hippocampal contouring. 
 
Material and Methods: Two clinical oncologists from 
different UK radiotherapy centres and a radiologist from each 
centre independently outlined the hippocampus on 2 
different 1 mm slice thickness planning CT datasets after 
registration with the T1 weighted gadolinium enhanced MRI 
(3D volumetric MRI, axial acquisition, 1 mm slice thickness, 
no slice gap, 1 x 1 x 1 mm voxels) on their planning system. 
The datasets were re-registered by one of the centres. The 
four hippocampal contours for each case were anonymised 
and reviewed collectively and a gold standard contour 
defined. We compared each contour with its respective gold 
standard using the DICE coefficient and volume difference. 
Results: 
 
Table 1 
 
Conclusion: Reasonable concordance of the outlines in 
comparison to the gold standard was achieved in both cases. 
In case 1, all 4 outlines achieved a DICE coefficient greater 
than 0.80 and a hippocampal volume less than 0.5cm3 
different to the gold standard. However, in case 2, despite 
DICE coefficients greater than 0.79 suggesting good spatial 
relationship between the clinicians’ and the gold standard 
contour, greater variability was evident with a larger range in 
volume outlined. During collective review, some systematic 
differences were noted between the two participating 
centres’ outlines, despite a high level of agreement on 
hippocampal boundaries during the review, highlighting CT-
MRI co-registration as a potential source of variability 
between different centres and planning software. As a result 
of these findings, the pre-trial outlining benchmark case 
requires all centres to independently co-register the CT and 
MRI images and export the registration object as part of data 
submission. In order to comprehensively quality assure 
hippocampal outlining as part of the HIPPO RTQA programme, 
an on-trial component of the first two HS patient contours 
being reviewed prospectively before treatment is also 
undertaken. The implementation and quality assurance of 
less familiar outlining practice in the development of 
radiotherapy techniques requires careful consideration. This 
process has informed the development of a dedicated RTQA 
programme for the HIPPO trial highlighting the importance of 
aligning QA with clinical practice. HIPPO is funded by Cancer 
Research UK and The Brain Tumour Charity  
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Purpose or Objective: The ViewRay MRI-Co60 hybrid system 
(MRIdian® [1,2]) is a novel technology that provides soft 
tissue imaging during radiotherapy thus allowing real 
adaptive radiotherapy possibilities and image guidance. The 
combination of Co60 with 0.35 Tesla MRI allows for MR-
guided intensity modulated radiation therapy (IMRT) step and 
shoot delivery with multiple beams (3 Co60 heads 120° 
apart). MRIdian dose calculation takes advantage of a full 
Monte Carlo-based algorithm. The aim of this work was to 
evaluate the repeatability of the dose calculation of MRIdian 
plans for rectal cancer treatments. 
 
Material and Methods: Ten patients affected by locally 
advanced rectal cancer (cT3-cT4; cN0, cN+) were manually 
segmented on Eclipse TPS v11. MRIdian step and shoot IMRT 
plans (7 groups of 3 fields each) were calculated 5 times for 
each patient. The prescribed dose for PTV2 was 45 Gy and 55 
Gy for PTV1 through simultaneous integrated boost. The PTV1 
V95, the conformity index CI [3] and the Wu’s homogeneity 
index HI were computed for each patient. The coefficient of 
variation (CV), defined as the ratio of the standard deviation 
to the mean, was calculated for each set to express the 
precision and repeatability of the Monte Carlo dose 
calculation. The estimated beam-on time was also recorded 
for each plan.  
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Results: The time for the optimization and the final dose 
calculation was less than 5 minutes for each plan having a 
total of 21 fields (7 groups of 3 heads). The mean CV for the 
conformity index was found to be equal to 1.6±0.5% whilst 
both the mean V95(PTV1) and the HI resulted in a CV smaller 
than 1%. The CV for the estimated beam-on time for the 10 
patients was found to be 4.3±2.1% (mean±std). 
 
Conclusion: MRI-guided radiotherapy is a novel approach that 
may be advantageous over current treatment techniques by 
allowing PTV reduction. Dose optimization and calculation 
time is done with full Monte Carlo with a very short 
calculation time. 
The three plan parameters under consideration proved that 
the Monte Carlo dose calculation is stable with a difference 
of the order of 4% in the estimated beam-on time.  
[1] Dempsey JF et al. A realtime MRI guided external beam 
radiotherapy delivery system. Med Phys 2006;33:2254 
[2] Dempsey JF, et al. A device for realtime 3D image guided 
IMRT. Int J Radiat Oncol Biol Phys 2005;63:S202 
[3] Saenz et al. A dose homogeneity and conformity 
evaluation between Viewray and Pinnacle-based linear 
accelerator IMRT treatment plans. J Med Phys. 2014 Apr-Jun; 
39(2): 64–70. 
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Purpose or Objective: Spine SBRT is an emerging treatment 
for patients with spinal metastases and rapidly being adopted 
in the clinic without treatment planning evaluation 
guidelines. Although the a priori treatment planning 
constraints were met in all cases in our previous study, large 
inter-institutional variations in 95% of the PTV volume (D95) 
and D50 were observed. The purpose of this study was to 
minimize the inter-institutional variations in planning. 
 
Material and Methods: Seven institutions in Japan, Canada, 
Singapore and USA participated and planned three cases with 
a total of ten apparatus. The spine cases included a 5th 
lumbar spine (case 1), 5th thoracic spine (case 2), and 10th 
thoracic spine metastases (case 3). Targets and organs at risk 
(OAR) were contoured by one experienced radiation 
oncologist according to International Spine Radiosurgery 
Consortium Consensus Guidelines and a 2 mm planning target 
volume (PTV) applied. The DICOM files were sent to each 
institute for planning. The treatment planning guidelines in 
the previous study included, prescribed dose of 24 Gy in two 
fractions with more than 70% prescribed dose to encompass 
D95, D0.035 &lt; 140% of the prescribed dose, and a 
maximum dose to the spinal cord planning organ at risk 
volume (PRV) or thecal sac &lt; 17 Gy. New guidelines added 
(D95 should be as high as possible(AHAP), D50 should be 
between 110% to 115% of prescribed dose and AHAP and 
D0.035 should be between 125% to 135% of the prescribed 
dose). The dose volume histograms (DVHs) were centrally 
reviewed. 
 
Results: In our previous study the PTV D95 ranged from 70.0% 
to 99.6 % in case 1 (mean &plusmn; SD; 21.21 &plusmn; 2.43 
Gy), 70.4% to 98.8% in case 2 (20.32 &plusmn; 2.22 Gy), and 
70.0% to 94.2% in case 3 (19.78 &plusmn; 1.97 Gy), 
respectively and D50 for PTV ranged from 99.2% to 116.3% in 
case 1 (25.62 &plusmn; 1.34 Gy), 91.7% to 119.6% in case 2 
(25.97 &plusmn; 2.18 Gy) and 84.2% to 114.2% in case 3 
(25.57 &plusmn; 2.14 Gy), respectively. In this study PTV D95 
ranged from 80.4% to 100.0% in case 1 (21.96 &plusmn; 1.67 
Gy), 76.3% to 95.8% in case 2 (20.91 &plusmn; 1.67 Gy), and 
70.4% to 94.2% in case 3 (20.3 &plusmn; 1.86 Gy), 
respectively and D50 for PTV ranged from 109.6% to 115.4% in 
case 1 (27.02 &plusmn; 0.53 Gy), 110.0% to 117.5% in case 2 
(27.06 &plusmn; 0.63 Gy) and 107.5% to 115.0% in case 3 
(26.89 &plusmn; 0.67 Gy), respectively. 
 
Conclusion: We succeeded to minimize the inter-institutional 
variations. This study highlights dose constraints of D95, D50 
and D0.035 should be used to minimize the variations. 
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Purpose or Objective: The use of nanoparticles (NP) in 
cancer therapy has been intensively investigated in the last 
few years. The advantage of using metal NP (such as gold, 
platinum, silver, hafnium oxide) during radiotherapy is that 
the amount of secondary electrons produced by the primary 
particles is higher than for soft tissue. Due to this enhanced 
secondary-electron emission around NP, stronger DNA 
damage is caused in the surrounding cells. The enhancement 
of energy deposition around gold NP has been determined in 
a number of studies, often with contradictory results, thus 
showing that the absorbed dose is not the appropriate 
physical quantity to estimate DNA damage in the presence of 
gold. Therefore it is necessary to systematically investigate 
the dependence of DNA damage from the spectra of the 
emitted secondary electrons and from corresponding 
nanodosimetric parameters. 
 
Material and Methods: In this work, the secondary electron 
spectra produced inside and around gold NP were determined 
by means of Monte-Carlo simulations. The transport of 
secondary electrons created by different clinical photon 
sources inside and emerging from a NP surrounded by water 
was simulated using Geant4. The secondary electron 
spectrum inside gold NP of two different sizes (diameter: 12 
and 30 nm) was calculated for mono-energetic photon 
sources (10 and 60 keV), an intra-operative x-ray source 
(maximum energy 50 keV), a conventional x-ray tube (200 
keVp) and a clinical linear accelerator (6 MV).  
 
Results: The energy spectra of the secondary electrons 
created inside the NP have a mean energy varying between 
about 6 keV for the mono-energetic 10-keV photons and 
about 65 keV for the 6-MV spectrum. This corresponds to a 
decrease of the mean ionization cluster size of about a factor 
of four for the linear accelerator. Therefore a corresponding 
decrease of the number of induced DNA double strand breaks 
is expected. Moreover, the spectra inside and around the 
gold NP with a diameter of 12 nm barely distinguish from 
those inside the gold NP with a diameter of 30 nm. However, 
the total amount of secondary electrons emerging from the 
smaller gold NP is increased by about a factor of three.  
 
Conclusion: Further studies will be carried out in the future 
for determining the correlation between secondary electrons 
production and ionization cluster size distributions for other 
NP diameters and materials. Finally, a comparison between 
physical damage at nanometric level and cell survival 
experiments will be also performed.  
 
 
